Related Experiment Video
Updated: Jul 2, 2025
11:44
A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
12.0K
DUSP4 modulates RIG-I- and STING-mediated IRF3-type I IFN response
Huipeng Jiao1,2,3, Sharmy J James2,3, Chin Wen Png2,3
1Zhejiang Provincial Key Laboratory of Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University, Hangzhou, Zhejiang, 310058, China.
Cell Death and Differentiation
|February 22, 2024
Summary
Dual-specificity phosphatase 4 (DUSP4) regulates type I interferon production by controlling key signaling proteins. DUSP4 deficiency enhances resistance to viral infections but increases susceptibility to malaria.
Area of Science:
- Immunology
- Molecular Biology
- Virology
Background:
- Type I interferons (IFNs) are crucial for antiviral defense but also implicated in autoimmune diseases.
- Understanding the regulation of type I IFN production is vital for controlling infections and autoimmune conditions.
Purpose of the Study:
- To investigate the role of DUSP4 phosphatase in innate immune signaling pathways.
- To elucidate the regulatory mechanisms governing type I IFN production.
Main Methods:
- Investigated DUSP4's function in a signaling complex involving TBK1, ERK1/2, and IRF3.
- Utilized DUSP4-deficient mice to assess in vivo responses to viral and parasitic infections.
Main Results:
- DUSP4 was identified as a critical regulator of TBK1 and ERK1/2 activation.
- DUSP4 deficiency resulted in altered type I IFN production.
- DUSP4-deficient mice showed increased resistance to RNA and DNA viruses.
- DUSP4-deficient mice exhibited enhanced susceptibility to malaria parasites.
Conclusions:
- DUSP4 acts as a key regulator of nucleic acid sensor signaling pathways.
- DUSP4 plays a significant role in the type I IFN regulatory system.
- DUSP4 modulation impacts host defense against diverse pathogens.
More Related Videos
Related Concept Videos
01:31Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
01:11IP3/DAG Signaling Pathway
12.1K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.1K
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
01:23RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
01:20The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
02:30siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K